A multi-cancer CRISPR/Cas9 reveals distinct gene dysregulation by noncoding MSTRG transcripts
RNA-seq (gene expression) · human · 24 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 24 samples: 3 × A549-MSTRG-2513-6_KO_S vs 3 × A549-MSTRG-4401-1_KO_S vs 3 × HCT116-MSTRG-2513-6_KO_S vs 3 × HCT116-MSTRG-4401-1_KO_SGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Substantial unannotated noncoding transcripts in tumors may transcriptionally regulate cancer-related genesBMC biology · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE229846_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA956439 and SRA study SRP432947. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 24 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7179030 A549-MSTRG-2513-6_KO_S17 A549-MSTRG-2513-6_KO_S
- GSM7179031 A549-MSTRG-2513-6_KO_S18 A549-MSTRG-2513-6_KO_S
- GSM7179032 A549-MSTRG-2513-6_KO_S19 A549-MSTRG-2513-6_KO_S
- GSM7179033 A549-MSTRG-4401-1_KO_S23 A549-MSTRG-4401-1_KO_S
- GSM7179034 A549-MSTRG-4401-1_KO_S24 A549-MSTRG-4401-1_KO_S
- GSM7179035 A549-MSTRG-4401-1_KO_S25 A549-MSTRG-4401-1_KO_S
- GSM7179036 A549-1B_WT_S20
- GSM7179037 A549-2B_WT_S21
- GSM7179038 A549-3B_WT_S22
- GSM7179039 HCT116-MSTRG-2513-6_KO_S11 HCT116-MSTRG-2513-6_KO_S
- GSM7179040 HCT116-MSTRG-2513-6_KO_S8 HCT116-MSTRG-2513-6_KO_S
- GSM7179041 HCT116-MSTRG-2513-6_KO_S9 HCT116-MSTRG-2513-6_KO_S
- GSM7179042 HCT116-MSTRG-4401-1_KO_S10 HCT116-MSTRG-4401-1_KO_S
- GSM7179043 HCT116-MSTRG-4401-1_KO_S15 HCT116-MSTRG-4401-1_KO_S
- GSM7179044 HCT116-MSTRG-4401-1_KO_S16 HCT116-MSTRG-4401-1_KO_S
- GSM7179045 HCT116-1B_WT_S12
- GSM7179046 HCT116-2B_WT_S13
- GSM7179047 HCT116-3B_WT_S14
- GSM7179048 HCT116-MSTRG-34636-7_KO-1A
- GSM7179049 HCT116-MSTRG-34636-7_KO-2A
- GSM7179050 HCT116-MSTRG-34636-7_KO-3A
- GSM7179051 HCT116-WT-1A
- GSM7179052 HCT116-WT-2A
- GSM7179053 HCT116-WT-3A
- GSE330047 CRISPR/Cas9-MEDIATED PHOX2B FUNCTIONAL KNOCK-OUT IN IMR32 NEUROBLASTOMA CELLS IMPAIRS NEURONAL EXCITABILITY THROUGH DYSREGULATION OF ION CHANNELS GENES 13 samples shares crispr, cas9, dysregulation
- GSE290621 Quadruple adenine base edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease engineered T cells [RNA-seq] 33 samples shares crispr, cas9
- GSE303100 Dissecting Resistance to CDK4/6 Inhibition in Experimental Glioma via Genome-wide CRISPR-Cas9 Screening 24 samples shares crispr, cas9
- GSE240468 Silencing of NFYC-AS1 by Gapmer antisense oligonucleotides and CRISPR/Cas9 TSS deletion. 23 samples shares crispr, cas9
- GSE283554 A CRISPR/Cas9-based enhancement of high-throughput single-cell transcriptomics 22 samples shares crispr, cas9
- GSE310675 CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer 12 samples shares crispr, cas9
- GSE311621 RNAseq profiling of eSCC human cell line (KYSE-410) knocked-out for SHIP2 using CRISPR/Cas9 technology 10 samples shares crispr, cas9
- GSE244257 Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6 mediated gene editing in hematopoietic stem cells 83 samples shares crispr, cas9
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.